The impact of sleep apnea on blood sugar control in adults with type 1 diabetes
Obstructive sleep apnea and glycemic dysregulation in adults with type 1 diabetes
This study is looking at how sleep apnea might affect blood sugar control in adults with type 1 diabetes, and it will involve trying out two different sleep treatments to see how they impact blood sugar levels.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10947955 on NIH RePORTER |
What this research studies
This research investigates how obstructive sleep apnea (OSA) affects blood sugar regulation in adults with type 1 diabetes (T1D). It aims to understand the relationship between OSA and glycemic control, as many adults with T1D experience poor blood sugar management and increased cardiovascular risks. The study will involve a sleep intervention where participants will undergo two different conditions: one where their OSA is untreated and another where it is treated using CPAP therapy. By comparing these conditions, researchers hope to uncover the mechanisms by which OSA may worsen blood sugar levels in T1D patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older with type 1 diabetes who have been diagnosed with obstructive sleep apnea.
Not a fit: Patients without type 1 diabetes or those who do not have obstructive sleep apnea may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management strategies for blood sugar control in adults with type 1 diabetes who also suffer from obstructive sleep apnea.
How similar studies have performed: Previous research has indicated a strong link between obstructive sleep apnea and glycemic dysregulation, suggesting that this approach may yield valuable insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Tasali, Esra — University of Chicago
- Study coordinator: Tasali, Esra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.